An unusual about-face that played out at the FDA over the last week illustrated the power of the “Make America Healthy Again” ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) has officially entered the most critical phase of its development ...

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Following constructive FDA feedback on its proposed statistical analysis plan, Clene plans to analyze the neurofilament light data from its large NIH-sponsored Early Access Protocol early in the ...

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...

Bombshell at RENK! Order intake is exploding! Revenue and earnings are also already up significantly. After Rheinmetall and ...

The Series 10 offers the most variety of Apple's smartwatches, giving you the choice of two metals for the case, aluminum or ...

What parents should know about heavy metals such as lead, cadmium, and arsenic: How EllaOla sets a cleaner standard.

A Bold Step for Public Health, Fueled by Conservative Principles In a groundbreaking initiative, the U.S. government has unveiled plans to develop universal va ...

MediPharm Labs Corp. shares T.LABS are trading down $0.02 at $0.08.

"More like AC/DC than the Wiggles", Clarity Pharmaceuticals is looking to make it big in the US with Australian tech.